{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:33:40Z","timestamp":1789583620937,"version":"build-2803163510"},"reference-count":54,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Evidence Based Medicine"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The quality of drug clinical trials is crucial for authorizing new drugs and fostering innovations in clinical practice. This study aimed to report the status, trends, and factors of the quality of drug clinical trials in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This mixed methods study assessed trial quality using quantitative data from public sources and qualitative data from focus groups and interviews with key stakeholders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The No Action Indicated findings issued by the Food and Drug Administration increased from 43% from 2009\u20132015 to 88% from 2016\u20132022, whereas the Official Action Indicated findings decreased from 9% to 0% (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). The Center for Food and Drug Inspection revealed that 12% of new drug applications in 2015\u20132017 were suspected of data fabrication, compared to only 0.6% failed to pass the inspection in 2022 (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Number of drug trials published by Chinese institutions in top medical journals increased from 1.3% in 2009 to 4.9% in 2022 (\n                      <jats:italic>p for trend<\/jats:italic>\n                      &lt;0.001). Moreover, the number of clinical trial guidelines increased from approximately 10\/year from 2015\u20132019 to 50\u201360\/year from 2020\u20132022, number of internationally accredited ethics committees increased from 4 in 2009 to 82 in 2022, and over 130,000 individuals received training on the International Council for Harmonization guidelines. Interviews with stakeholders revealed a consensus on quality improvement, attributed to seven key factors, and highlighted further recommendations to enhance clinical trial quality in China.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The quality of drug clinical trials in China has significantly improved over the past decade, yet there remains scope for further enhancement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jebm.70085","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:36:16Z","timestamp":1762504576000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quality of Drug Clinical Trials in China: A Mixed Methods Research"],"prefix":"10.1111","volume":"18","author":[{"given":"Xiayan","family":"Chen","sequence":"first","affiliation":[{"name":"Peking University First Hospital  Beijing China"},{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine Peking University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Chu","sequence":"additional","affiliation":[{"name":"Research Center of Clinical Epidemiology Peking University Third Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine Peking University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine Peking University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxue","family":"Meng","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine Peking University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine Peking University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1901642"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03651-5"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx086"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-022-00417-w"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.22"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102177"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k547"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00483-1"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4260"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.94"},{"issue":"1","key":"e_1_2_9_13_1","first-page":"101","article-title":"Clinical Trial Design in the Era of Precision Medicine","volume":"14","author":"Fountzilas E.","year":"2022","journal-title":"Genomic Medicine"},{"key":"e_1_2_9_14_1","unstructured":"Central People's Government of the People's Republic of China.Opinions on Deepening the Reform of the Evaluation and Approval System and Inspiring Innovation of Drugs and Medical Devices 2017 [cited 2024 April 22] https:\/\/www.gov.cn\/zhengce\/2017\u201010\/08\/content_5230105.htm."},{"key":"e_1_2_9_15_1","unstructured":"Central People's Government of the People's Republic of China.Opinions on the Reform of Evaluation and Approval System for Drugs and Medical Devices 2015 [cited 2024 April 22] https:\/\/www.gov.cn\/zhengce\/content\/2015\u201008\/18\/content_10101.htm."},{"key":"e_1_2_9_16_1","unstructured":"Center for Drug Evaluation.China Drug Trials Website 2024 [cited 2024 December 24] http:\/\/www.chinadrugtrials.org.cn\/index.html."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5396"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12117"},{"key":"e_1_2_9_19_1","unstructured":"Center for Food and Drug Inspection of NMPA.Interim Report On Drug Clinical Trial Data Inspection 2017 [cited 2025 February 11] https:\/\/www.cfdi.org.cn\/resource\/attachment\/ueFile\/2017\/07\/RnJpIEp1bCAyMSAxNDoxNDo0MyAyMDE3NjYxMzU=.pdf."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12295"},{"key":"e_1_2_9_21_1","unstructured":"Center for Food and Drug Inspection of NMPA.2022 Annual Drug Inspection Report 2023 [cited 2024 October 7] https:\/\/www.cfdi.org.cn\/resource\/news\/15638.html."},{"key":"e_1_2_9_22_1","unstructured":"Center for Drug Evaluation.ICH Guidelines 2024 [cited 2024 November 1] https:\/\/www.cde.org.cn\/ichWeb\/guideIch\/toGuideIch\/5\/1."},{"key":"e_1_2_9_23_1","unstructured":"Center for Food and Drug Inspection of NMPA.China's Drug Clinical Trial Institution Record\u2010Keeping System 2024 [cited 2024 November 1] https:\/\/beian.cfdi.org.cn\/CTMDS\/apps\/pub\/drugPublic.jsp."},{"key":"e_1_2_9_24_1","unstructured":"DIA.ICH Theme Day | China Enters a New Era in ICH 2022 [cited 2024 December 18] https:\/\/www.diaglobal.org.cn\/newsinfo\/4856882.html?templateId=1793749."},{"key":"e_1_2_9_25_1","unstructured":"Xinhua News Agency.Establishment of 50 National Clinical Research Centers in China 2022 [cited 2025 February 11] https:\/\/www.gov.cn\/xinwen\/2022\u201008\/25\/content_5706815.htm."},{"key":"e_1_2_9_26_1","unstructured":"Xinhua News Agency.China Establishes 13 Specialized National Medical Centers 2023 [cited 2025 February 11] https:\/\/www.gov.cn\/lianbo\/2023\u201004\/13\/content_5751357.htm."},{"key":"e_1_2_9_27_1","unstructured":"National Health Commission.Ethical Review Measures for Life Science and Medical Research involving Humans 2023 [cited 2024 March 9] https:\/\/www.gov.cn\/zhengce\/zhengceku\/2023\u201002\/28\/content_5743658.htm."},{"key":"e_1_2_9_28_1","unstructured":"National Medical Products Administration.Procedures for Supervision Inspection of Drug Clinical Trial Institutions (Trial) 2023 [cited 2024 December 28] https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ypqtggtg\/20231103175749117.html."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12528"},{"key":"e_1_2_9_30_1","first-page":"1","article-title":"International Comparison and Assessment of the Quality of Drug Clinical Trial Implementation in China Based on Scientific Regulatory System","volume":"45","author":"Fang H.","year":"2023","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-022-00441-w"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.10.004"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o41"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1631"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-083957"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2023.100254"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-021-00297-1"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2019.09.004"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.31486\/toj.19.0085"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1052977"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13111"},{"issue":"15","key":"e_1_2_9_42_1","first-page":"1689","article-title":"Enhancing Quality and Efficiency of Clinical Trial Management in Hospitals by Quality Management System","volume":"35","author":"Niu X.","year":"2019","journal-title":"The Chinese Journal of Clinical Pharmacology"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103925"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-2020-5"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13641"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221078216"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-5213"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.105918"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31816b9027"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774516643491"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774518755056"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3702-z"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpor.2011.01.004"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-00753-x"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000705"}],"container-title":["Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jebm.70085","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jebm.70085","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jebm.70085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:41:13Z","timestamp":1769946073000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jebm.70085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/jebm.70085"],"URL":"https:\/\/doi.org\/10.1111\/jebm.70085","archive":["Portico"],"relation":{},"ISSN":["1756-5383","1756-5391"],"issn-type":[{"value":"1756-5383","type":"print"},{"value":"1756-5391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2025-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70085"}}